Patient Safety & Outcomes

A CDC analysis published Nov. 18 predicts that when the nationwide intensive care unit bed capacity hits or exceeds 75 percent, thousands of additional excess deaths occur over the following two weeks. 

A new study from Children's National Hospital in Washington, D.C., found that patients with multisystem inflammatory syndrome in children — a rare but serious immune response linked to COVID-19 — had more severe illness during the second wave of patients…

COVID-19 hospitalizations in Colorado are at record high levels for 2021 and nearing totals seen during last winter's surge, Colorado Public Radio News reported Nov. 17. 

Cancer patients and other people taking immune-suppressing medications do not have an overall higher risk of dying from COVID-19, according to a study involving more than 200,000 hospitalized COVID-19 patients. 

As the U.S. enters its regular flu season, there's still a lot unknown about coinfection of flu and SARS-CoV-2 viruses. 

People taking certain antidepressants, particularly fluoxetine, may have a lower death risk from COVID-19, according to research published Nov. 15 in JAMA Network Open.

Medical understanding of pulmonary arterial hypertension (PAH) has come a long way in the last 20 years.1,2 Today, the medical community has a much clearer picture of the pathophysiology of this disease.1

The number of patients hospitalized for COVID-19 at Henry Ford Health System has increased by nearly 60 percent since late October, the Detroit-based system said Nov. 16.

Medicare Advantage members who frequented providers with value-based care arrangements spent significantly less time in a hospital than non-value-based members. 

The combination of staffing shortages, longer patient stays and unmet behavioral health needs is leaving Massachusetts hospitals bracing for "yet another difficult winter," according to the head of the state's hospital association.